AGP Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0113801010
PKR
187.01
-1.08 (-0.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About AGP Ltd. stock-summary
stock-summary
AGP Ltd.
Pharmaceuticals & Biotechnology
AGP Limited is a Pakistan-based pharmaceutical company that manufactures, markets and distributes pharmaceutical and healthcare products. The Company provides products in the areas of anti-infective, antihistamines, antidepressants, anti fibrinolytic, antiobesity, bile therapy and cholagogue, iron preparation, narcotic analgesic, proton pump inhibitor, vitamin B12, anti-inflammatory enzyme, anti-diarrheal, antidiabetic, anti haemorrhoidal, antispasmodics, calcium preparation, medical food supplement, non-narcotic analgesic, tonic, vitamin D plain, anti allergics, antibiotics, antidiarrheal supplement, antimalarial, antiviral, expectorant, muscle relaxant and venotropic agent. The Company sells products under various brands, including Ceclor, Rigix, Osnate, Anafortan, MyHep, Keflex, Chymoral Forte, Splasler P, Urso and Rubifer.
Company Coordinates stock-summary
Company Details
B-23, S.I.T.E , Karachi None : 75700
stock-summary
Tel: 92 21 111247247
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
7,160 Million
(Quarterly Results - Mar 2025)
Net Profit:
1,057 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

PKR 53,390 Million (Large Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.10%

stock-summary
Debt Equity

0.69

stock-summary
Return on Equity

29.80%

stock-summary
Price to Book

3.75